Power and water costs are becoming harder to ignore
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
AbCellera Biologics Inc. (NASDAQ:ABCL) rallied for a third consecutive day on Monday to hit a new three-year high, after its drug candidate for hot flashes in menopausal women achieved strong clinical trial results, sparking long-term rosy growth prospects. In intra-day trading, the stock surged to a record high of $10.01 before trimming gains to end […]
Advertiser demand is becoming harder for investors to ignore
The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one of healthcare’s fastest-growing markets. Yet another competitive advantage for investors to […]
Investors want proof that massive demand can produce cash flow
Strategic buyers are chasing scarce real-time AI technology
Two robot ETFs now compete for the same investor thesis, but their portfolios tell completely different stories about where humanoid money actually flows when production lines start moving.
Turning 65 comes with a quiet IRS bonus most retirees overlook, and the way you deploy it in the next few months could determine whether your retirement generates real monthly cash or simply keeps pace with inflation.
Intel (NASDAQ:INTC) shares have nearly tripled this year, outrunning AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), and the Philadelphia Semiconductor Index’s nearly 75% climb. On August 10, the company said it would sell $15 billion of new stock to fund its push into contract chip manufacturing, and shares fell more than 4% in early trading. That marked a […]
CFO executed a sale under a Rule 10b5-1 plan and retains 767,045 shares worth ~$15 million after the disposition.
Investing.com -- Morgan Stanley downgraded its view on cross-border e-commerce platform Global-e Online to Equal-weight from Overweight, saying the market now better reflects the company’s durable growth and competitive position. The bank nevertheless raised its price target to $44 from $37 as it rolled its valuation framework forward to 2028 and incorporated the impact of the Passport acquisition.
Investing.com -- Rocket Lab Corp (NASDAQ:RKLB) reported second quarter results that missed earnings expectations despite posting record revenue, with shares falling 1.6% in after-hours trading Monday.
The relationship between Tesla Inc CEO Elon Musk and President Donald Trump has been mostly positive since their notorious spat last year. After all, the billionaire poured hundreds of millions of dollars into Trump’s 2024 campaign and remains a key...
The company reported a loss of $238.1 million for the second quarter, compared with a loss of $20 million in the same quarter a year earlier.
Archer Aviation just made its boldest move yet, snapping up three Boeing businesses.
Funding could accelerate growth while adding new financial risks
Hims & Hers Health shares are down after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year. Madison Muller reports on "Bloomberg The Close."
RBC Bearings currently trades at $566.59 per share and has shown little upside over the past six months, posting a middling return of 3.4%. The stock also fell short of the S&P 500’s 10.9% gain during that period.
Super Micro Computer is scheduled to report earnings after the closing bell Tuesday, with traders anticipating a big move in the AI server maker’s stock
Moby summary of Target Hospitality Corp.'s Q2 2026 earnings call

<body><p>STORY: "We think the fundamentals are positive," on healthcare companies, Isherwood said. "We also think AI tools have potential to help drug development accelerate."</p><p>But the AI trade itself is "concerning," he said.</p><p>"We've watched, actually the credit markets where we've seen Oracle CDS (credit default swaps) blow to levels consistent with where they were last in the financial crisis," Isherwood explained. "We've also seen Nvidia's tick up past 50 basis points, which we consider the market starting to show a little bit of stress, and warning that some of these players may not be able to pay their bills in future years."</p></body>
The Dutch-American chipmaker beat Street estimates on both lines in Q2 2026. The stock fell anyway.
Plug Power (PLUG) delivered earnings and revenue surprises of +12.50% and +6.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -7.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ALTI GLOBAL INC (ALTI) delivered earnings and revenue surprises of -250.00% and -6.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Archer Aviation (ACHR) delivered earnings and revenue surprises of 0.00% and +156.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
NuScale Power is on the brink of a $10 trillion market opportunity.
The chip maker announces partnerships with Goldman Sachs, BlackRock, Blackstone, Apollo, Brookfield, and KKR to finance data centers.
Over the last six months, PTC’s shares have sunk to $146.31, producing a disappointing 8.4% loss - a stark contrast to the S&P 500’s 10.9% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.